Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 37

    1.

    The potent different risk factors for cerebral infarction in young patients with and without type 2 diabetes: subanalysis of the Young Cerebral Infarction Study (YCIS).

    Zhang B, Gao C, Hou Q, Yin J, Xie L, Pu S, Yi Y, Gao Q.

    Atherosclerosis. 2012 Mar;221(1):215-20. Epub 2011 Dec 27.

    PMID:
    22245036
    [PubMed - in process]
    2.

    Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabetes: a population-based study.

    Panero F, Gruden G, Perotto M, Fornengo P, Barutta F, Greco E, Runzo C, Ghezzo G, Cavallo-Perin P, Bruno G.

    Atherosclerosis. 2012 Mar;221(1):183-8. Epub 2011 Dec 26.

    PMID:
    22239868
    [PubMed - in process]
    3.

    Thioredoxin interacting protein genetic variation is associated with diabetes and hypertension in the Brazilian general population.

    Ferreira NE, Omae S, Pereira A, Rodrigues MV, Miyakawa AA, Campos LC, Santos PC, Dallan LA, Martinez TL, Santos RD, Mill JG, Krieger JE, Pereira AC.

    Atherosclerosis. 2012 Mar;221(1):131-6. Epub 2011 Dec 22.

    PMID:
    22236479
    [PubMed - in process]
    4.

    Adiponectin G276T gene polymorphism is associated with cardiovascular disease in Japanese patients with type 2 diabetes.

    Katakami N, Kaneto H, Matsuoka TA, Takahara M, Maeda N, Shimizu I, Ohno K, Osonoi T, Kawai K, Ishibashi F, Imamura K, Kashiwagi A, Kawamori R, Matsuhisa M, Funahashi T, Yamasaki Y, Shimomura I.

    Atherosclerosis. 2012 Feb;220(2):437-42. Epub 2011 Nov 16.

    PMID:
    22138143
    [PubMed - indexed for MEDLINE]
    5.

    Ezetimibe alone and in combination lowers the concentration of small, dense low-density lipoproteins in type 2 diabetes mellitus.

    Winkler K, Jacob S, Müller-Schewe T, Hoffmann MM, Konrad T.

    Atherosclerosis. 2012 Jan;220(1):189-93. Epub 2011 Nov 9.

    PMID:
    22115011
    [PubMed - indexed for MEDLINE]
    6.

    Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice.

    Iwabayashi M, Taniyama Y, Sanada F, Azuma J, Iekushi K, Kusunoki H, Chatterjee A, Okayama K, Rakugi H, Morishita R.

    Atherosclerosis. 2012 Feb;220(2):337-42. Epub 2011 Nov 9.

    PMID:
    22172591
    [PubMed - indexed for MEDLINE]
    7.

    Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes.

    Okada H, Fukui M, Tanaka M, Inada S, Mineoka Y, Nakanishi N, Senmaru T, Sakabe K, Ushigome E, Asano M, Yamazaki M, Hasegawa G, Nakamura N.

    Atherosclerosis. 2012 Jan;220(1):155-9. Epub 2011 Nov 2.

    PMID:
    22100253
    [PubMed - indexed for MEDLINE]
    8.

    Qualitative score of systemic arteriosclerosis by vascular ultrasonography as a predictor of coronary artery disease in type 2 diabetes.

    Hirata A, Kishida K, Hiuge-Shimizu A, Nakatsuji H, Funahashi T, Shimomura I.

    Atherosclerosis. 2011 Dec;219(2):623-9. Epub 2011 Sep 3.

    PMID:
    21930272
    [PubMed - indexed for MEDLINE]
    9.

    The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cells.

    Prudente S, Morini E, Larmon J, Andreozzi F, Di Pietro N, Nigro A, Gervino EV, Mannino GC, Bacci S, Hauser TH, Bellacchio E, Formoso G, Pellegrini F, Proto V, Menzaghi C, Frittitta L, Pandolfi A, Sesti G, Doria A, Trischitta V.

    Atherosclerosis. 2011 Dec;219(2):667-72. Epub 2011 Aug 19.

    PMID:
    21907990
    [PubMed - indexed for MEDLINE]
    10.

    Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and cardiovascular risk and efficacy of atorvastatin among subjects with diabetes on dialysis: the 4D study.

    Hoffmann MM, März W, Genser B, Drechsler C, Wanner C.

    Atherosclerosis. 2011 Dec;219(2):659-62. Epub 2011 Aug 5.

    PMID:
    21871624
    [PubMed - indexed for MEDLINE]
    11.

    The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates β-cell insulin release.

    Koren-Gluzer M, Aviram M, Meilin E, Hayek T.

    Atherosclerosis. 2011 Dec;219(2):510-8. Epub 2011 Aug 4.

    PMID:
    21862013
    [PubMed - indexed for MEDLINE]
    12.

    Oral zinc supplementation does not improve oxidative stress or vascular function in patients with type 2 diabetes with normal zinc levels.

    Seet RC, Lee CY, Lim EC, Quek AM, Huang H, Huang SH, Looi WF, Long LH, Halliwell B.

    Atherosclerosis. 2011 Nov;219(1):231-9. Epub 2011 Jul 26.

    PMID:
    21840002
    [PubMed - indexed for MEDLINE]
    13.

    Lack of association between plasma PCSK9 and LDL-apoB100 catabolism in patients with uncontrolled type 2 diabetes.

    Vergès B, Duvillard L, Brindisi MC, Gautier E, Krempf M, Costet P, Cariou B.

    Atherosclerosis. 2011 Nov;219(1):342-8. Epub 2011 Jul 26.

    PMID:
    21889145
    [PubMed - indexed for MEDLINE]
    14.

    Zinc supplementation: another myth or we are heading towards a new era in the treatment of diabetes?

    Zampelas A.

    Atherosclerosis. 2011 Nov;219(1):22-3. Epub 2011 Jun 23. No abstract available.

    PMID:
    21764056
    [PubMed - indexed for MEDLINE]
    15.

    Does microvascular disease predict macrovascular events in type 2 diabetes?

    Rosenson RS, Fioretto P, Dodson PM.

    Atherosclerosis. 2011 Sep;218(1):13-8. Epub 2011 Jun 23. Review.

    PMID:
    21763654
    [PubMed - indexed for MEDLINE]
    16.

    Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis.

    Ullevig SL, Zhao Q, Zamora D, Asmis R.

    Atherosclerosis. 2011 Dec;219(2):409-16. Epub 2011 Jun 17.

    PMID:
    21752377
    [PubMed - indexed for MEDLINE]
    17.

    Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype.

    Farbstein D, Blum S, Pollak M, Asaf R, Viener HL, Lache O, Asleh R, Miller-Lotan R, Barkay I, Star M, Schwartz A, Kalet-Littman S, Ozeri D, Vaya J, Tavori H, Vardi M, Laor A, Bucher SE, Anbinder Y, Moskovich D, Abbas N, Perry N, Levy Y, Levy AP.

    Atherosclerosis. 2011 Nov;219(1):240-4. Epub 2011 Jun 13.

    PMID:
    21722898
    [PubMed - indexed for MEDLINE]
    18.

    Genetic variants of 11 telomere-pathway gene loci and the risk of incident type 2 diabetes mellitus: the Women's Genome Health Study.

    Zee RY, Ridker PM, Chasman DI.

    Atherosclerosis. 2011 Sep;218(1):144-6. Epub 2011 May 18.

    PMID:
    21665207
    [PubMed - indexed for MEDLINE]
    19.

    Skin autofluorescence is inversely related to HDL anti-oxidative capacity in type 2 diabetes mellitus.

    Mulder DJ, de Boer JF, Graaff R, de Vries R, Annema W, Lefrandt JD, Smit AJ, Tietge UJ, Dullaart RP.

    Atherosclerosis. 2011 Sep;218(1):102-6. Epub 2011 May 18.

    PMID:
    21665206
    [PubMed - indexed for MEDLINE]
    20.

    Combined atherogenic effects of celiac disease and type 1 diabetes mellitus.

    Pitocco D, Giubilato S, Martini F, Zaccardi F, Pazzano V, Manto A, Cammarota G, Di Stasio E, Pedicino D, Liuzzo G, Crea F, Ghirlanda G.

    Atherosclerosis. 2011 Aug;217(2):531-5. Epub 2011 May 6.

    PMID:
    21601206
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk